We laid out the Cambodia Industrial Park in 2013. Currently, the industrial park has more than ten industrial chains, including those of caffeine, sodium citrate, sulfadiazine, folic acid, etc., forming an integrated asset model that covers everything from raw materials to finished products. 

Raw materials and auxiliary materials are the starting point and cornerstone of Erkang. However, Erkang has not rested on its laurels. After taking the lead in the research, development, and mass production of starch capsules in 2014, Erkang has continuously maintained high investment in high-tech research and development. It adapts to market development through innovation and change, and builds a one-stop comprehensive service platform for the entire pharmaceutical process. With the Cambodia Industrial Park, the raw and auxiliary material production area, and the finished drug production area, it has initiated a new integrated pattern of "intermediates + raw and auxiliary materials + preparations", achieving a greater variety, larger scale, and more complete supporting facilities for products and services.